Argenica Therapeutics Ltd

NEW
ASX:AGN (Australia)   Ordinary Shares
A$ 0.15 +0.010 (+6.9%) Jul 22
At Loss
P/B:
5.74
Market Cap:
A$ 18.63M ($ 13.02M)
Enterprise V:
A$ 13.59M ($ 9.50M)
Volume:
256.45K
Avg Vol (2M):
423.83K
Trade In:
Volume:
256.45K
At Loss
Avg Vol (2M):
423.83K

Argenica Therapeutics Ltd (ASX:AGN) Dividend

Argenica Therapeutics Ltd (ASX:AGN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:AGN Dividend

Does Argenica Therapeutics Ltd (ASX:AGN) pay a dividend?

Argenica Therapeutics Ltd (ASX:AGN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Argenica Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Argenica Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -13.9% over the past 3 years.

What are dividend-paying alternatives to Argenica Therapeutics Ltd?

For dividend-paying alternatives in Argenica Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.